Hamilton Thorne Ltd. (HTL.TO)
| Previous close | 1.4000 |
| Open | 1.4100 |
| Bid | 1.4000 x N/A |
| Ask | 1.4200 x N/A |
| Day's range | 1.4000 - 1.4200 |
| 52-week range | 1.0500 - 1.5600 |
| Volume | |
| Avg. volume | 54,983 |
| Market cap | 218.322M |
| Beta (5Y monthly) | 0.28 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings date | 15 Aug 2024 - 19 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.27 |
Simply Wall St.Hamilton Thorne (TSE:HTL) shareholders have earned a 5.6% CAGR over the last five years
If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share...
GlobeNewswireHamilton Thorne Reports Record Revenue and EBITDA for the Quarter Ended March 31, 2024, and Confirms Annual Guidance
Revenue of $19.4 million and Adjusted EBITDA of $3.5 for the quarterBEVERLY, Mass. and TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software, and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the quarter ended March 31, 2024. Financial Highlights 1st quarter sales increased 16% to $19.4 million;
- GlobeNewswire
Hamilton Thorne to Announce Q1 2024 Financial Results and Hold Conference Call on May 14, 2024
BEVERLY, Mass. and TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three months ended March 31, 2024 before market open on Tuesday, May 14, 2024. The press release, with accompanying financial information, will be poste
